Explores the regulation of therapeutic products, covering classification, manufacturing, authorization, and advertising, emphasizing the importance of proper authorization for medicines.
Explores the regulatory environment for quality compliance in drug development and emphasizes the importance of preventative measures and documentation.
Delves into the molecular basis of genetic diseases, discussing specific examples like Phenylketonuria and Haemophilia A, and the development of small molecule drugs for genetic disorders.
Explores the EXSCALATE4COV project, focusing on computational drug discovery for COVID-19 treatments and the collaboration between academia and industry.
Explores kinase inhibitors, enzyme inhibition methods, transition state analog drugs, and the significance of covalent drugs in pharmaceutical research.
